{"id":1068198,"date":"2022-04-01T02:09:15","date_gmt":"2022-04-01T06:09:15","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/sellas-life-sciences-signs-exclusive-license-agreement-with-genfleet-therapeutics-for-next-generation-highly-selective-cdk9-inhibitor\/"},"modified":"2024-08-18T11:44:11","modified_gmt":"2024-08-18T15:44:11","slug":"sellas-life-sciences-signs-exclusive-license-agreement-with-genfleet-therapeutics-for-next-generation-highly-selective-cdk9-inhibitor","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/sellas-life-sciences-signs-exclusive-license-agreement-with-genfleet-therapeutics-for-next-generation-highly-selective-cdk9-inhibitor.php","title":{"rendered":"SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet Therapeutics for Next-Generation, Highly Selective CDK9 Inhibitor"},"content":{"rendered":"<p><![CDATA[- SELLAS In-licenses Worldwide Rights Outside of Greater China for Clinical-Stage Asset -]]><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/03\/31\/2414371\/0\/en\/SELLAS-Life-Sciences-Signs-Exclusive-License-Agreement-with-GenFleet-Therapeutics-for-Next-Generation-Highly-Selective-CDK9-Inhibitor.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet Therapeutics for Next-Generation, Highly Selective CDK9 Inhibitor\">SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet Therapeutics for Next-Generation, Highly Selective CDK9 Inhibitor<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more: SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet Therapeutics for Next-Generation, Highly Selective CDK9 Inhibitor <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/sellas-life-sciences-signs-exclusive-license-agreement-with-genfleet-therapeutics-for-next-generation-highly-selective-cdk9-inhibitor.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068198","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068198"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068198"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068198\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068198"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068198"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}